Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.
Anti-ischemic therapy with organic nitrates is complicated by tolerance. Induction of tolerance is incompletely understood and likely multifactorial. Recently, increased production of reactive oxygen species (ROS) has been investigated, but it has not been clear if this is a direct consequence of the organic nitrate on the vessel or an in vivo adaptation to the drugs. To examine the possibility that nitrates could directly stimulate vascular ROS production, we compared the development of nitrate tolerance with the formation of ROS induced by pentaerithrityltetranitrate (PETN) or nitroglycerin (GTN) in vitro in porcine smooth muscle cells, endothelial cells, washed ex vivo platelets and whole blood. By examining cGMP formation, it was found that 24-hr treatment with GTN but not PETN induced significant nitrate tolerance, which was prevented by parallel treatment with Vit C. Incubation of vascular cells acutely with 0.5 mM GTN doubled the rate of ROS generation, whereas PETN had no such effect. The rate of ROS (peroxynitrite and O2) formation detected by specific spin traps in tolerant smooth muscle cells, treated for 24 hr with 0.01 mM GTN, was substantially higher (30.5 nM/min) than in control cells acutely treated with 0.5 mM GTN (25 nM/min). In contrast to PETN, GTN induces nitrate tolerance and also increases the formation of ROS both in vascular cells and in whole blood. ROS formation is minimally stimulated by PETN comparable to data obtained in Vit C-suppressed GTN tolerance. ROS formation induced by organic nitrates seems to be a key factor in the development of nitrate tolerance.
Institute of Chemical Kinetics and Combustion, Novosibirsk 630090, Russia.
S
S
Dikalov
B
B
Fink
M
M
Skatchkov
D
D
Stalleicken
E
E
Bassenge
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D004361:Drug Tolerance; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D017665:Hydroxyl Radical / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009566:Nitrates / Q000378:metabolism* / Q000494:pharmacology*; D005996:Nitroglycerin / Q000378:metabolism*; D010417:Pentaerythritol Tetranitrate / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D019097:Spin Trapping; D013481:Superoxides / Q000378:metabolism; D013552:Swine
D009566:Nitrates; D017382:Reactive Oxygen Species; D010417:Pentaerythritol Tetranitrate; D013481:Superoxides; C039642:peroxynitric acid; D017665:Hydroxyl Radical; D005996:Nitroglycerin; D006152:Cyclic GMP